Stem Cells: Model, Target, & Therapy
Tuesday, 23 June 2020
Stem cells can drive clinical development in a diversity of ways. Stem cells can help identify new therapeutics through disease modeling, drug screening, and personalized medicine. Endogenous stem cells can be the targets of therapeutics, which can stimulate regeneration in vivo. Finally, stem cells or stem cell-derived products can be the therapeutic themselves, delivered to patients to replace or repair damaged tissues. The ISSCR’s Workshop on Clinical Translation will showcase speakers from academia and industry who will discuss various approaches to develop cellular therapies in this translationally-focused program. This year’s workshop explores the broad ways that stem cells are advancing pre-clinical research and clinical trials in three sessions:
- Modeling Stem Cells for Discovery
- Endogenous Stem Cells as Targets
- Stem Cells as Drugs in Clinical Trials
The Workshop on Clinical Translation is a full-day program hosted at the Boston Convention and Exhibition Center. A renowned panel of speakers will cover a range of topics from pre-clinical modeling to ongoing clinical trials.
Where: Boston Convention and Exhibition Center
Registration: Tuesday, 25 June 07:30-09:00; Boston Convention and Exhibition Center, North Lobby
Price : $205 (trainee members), $225 (full/affiliate members), $245 (nonmembers). All prices in USD.
|07:30 – 09:00||Registration with coffee and tea|
|09:00 – 09:10|
Welcome and opening remarks: Lee Rubin, Harvard University, USA
|SESSION I||Modeling Stem Cells for Discovery|
Moderator: Ricardo Dolmetsch, Novartis, USA
|09:10 – 09:40||Speaker 1 Giorgia Quadrato, University of Southern California, Keck School of Medicine, USA|
|09:40 – 10:10|
Speaker 2 Clifford Woolf, Boston Children's Hospital, USA
|10:10 – 10:40||Speaker 3 Ajamete Kaykas, Insitro, USA|
|10:40 – 11:10||Modeling Stem Cells for Discovery Panel Discussion|
|11:20 – 12:25||Lunch|
|SESSION 2||Endogenous Stem Cells as Targets|
Moderator: Chee-Yeun Chung, Yumanity, USA
|12:30 – 13:00||Speaker 1 Magdalena Goetz, Helmholtz Zentrum Muenchen, Germany|
|13:00 – 13:30||Speaker 2 TBD|
|13:30 – 14:00||Speaker 3 Albert Edge, Massachusetts Eye and Ear; Decibel Therapeutics, USA|
|14:00 – 14:30||Endogenous Stem Cells as Targets Panel Discussion|
|14:30 – 15:00||Coffee break|
|SESSION 3||Stem Cells as Drugs in Clinical Trials|
Moderator: Jerry Ritz, Dana Farber Cancer Institute, USA
|15:00 – 15:30||Speaker 1 David Williams, Boston Children’s Hospital, USA|
|15:30 – 16:00||Speaker 2 Agnete Kirkeby, University of Copenhagen, Denmark|
|16:00 – 16:30||Speaker 3 TBD|
|16:30 – 17:00||Stem Cells as Drugs Panel Discussion|
|17:00 – 17:10||Closing Remarks: Stacie Weninger, F-Prime Capital, USA|
Who Should Attend?
This program is designed for scientists, physicians, physician-scientists, and those interested in the latest clinical applications of stem cell research.
How to Register
You may register for the Workshop only or in conjunction with the ISSCR 2020 Annual Meeting. If you have already registered for ISSCR 2020 you may modify your registration to add the Workshop. Registration will be offered onsite only if there is space available. Seating is limited, however, and registration will close early if all seats are sold. Register early to reserve your spot!
Until 08 May, 2020
Please email a cancellation notice
No refunds will be granted.